Trends in US Emergency Department Visits for Anaphylaxis Among Infants and Toddlers: 2006-2015

Lacey B Robinson1, Anna Chen Arroyo2, Mohammad K Faridi3

  • 1Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Insights

Emergency department visits for anaphylaxis in infants and toddlers rose significantly from 2006 to 2015. However, hospitalizations for this severe allergic reaction decreased during the same period.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Public Health

Background:

  • Anaphylaxis is a severe, life-threatening allergic reaction.
  • While overall anaphylaxis prevalence is increasing in children, trends in infants and toddlers are understudied.

Purpose of the Study:

  • To analyze trends in emergency department (ED) visits and hospitalizations for anaphylaxis in US infants and toddlers between 2006 and 2015.

Main Methods:

  • A retrospective study using a national database of ED visits for children under 18.
  • Focused analysis on infants and toddlers (under 3 years) from 2006-2015, using ICD-9 codes for anaphylaxis.
  • Multivariable logistic regression identified predictors of hospitalization.

Main Results:

  • Anaphylaxis ED visits per 100,000 population increased from 15 to 32 (P < .001) in infants and toddlers.
  • The proportion of ED visits for anaphylaxis rose from 20 to 50 per 100,000 visits (P < .001).
  • Hospitalization proportion decreased from 19% to 6% (P < .001), with food as the most common trigger.

Conclusions:

  • Emergency department visits for anaphylaxis in infants and toddlers have significantly increased nationwide.
  • Despite increased ED visits, hospitalizations for anaphylaxis in this age group have decreased.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
30.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
105
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
130
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
104
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.4K